168 related articles for article (PubMed ID: 27107135)
1. Resveratrol Ameliorates Cardiac Hypertrophy by Down-regulation of miR-155 Through Activation of Breast Cancer Type 1 Susceptibility Protein.
Fan Y; Liu L; Fang K; Huang T; Wan L; Liu Y; Zhang S; Yan D; Li G; Gao Y; Lv Y; Chen Y; Tu Y
J Am Heart Assoc; 2016 Apr; 5(4):. PubMed ID: 27107135
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-223 displays a protective role against cardiomyocyte hypertrophy by targeting cardiac troponin I-interacting kinase.
Wang YS; Zhou J; Hong K; Cheng XS; Li YG
Cell Physiol Biochem; 2015; 35(4):1546-56. PubMed ID: 25792377
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy.
Dong DL; Chen C; Huo R; Wang N; Li Z; Tu YJ; Hu JT; Chu X; Huang W; Yang BF
Hypertension; 2010 Apr; 55(4):946-52. PubMed ID: 20177001
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.
Li Q; Xie J; Wang B; Li R; Bai J; Ding L; Gu R; Wang L; Xu B
PLoS One; 2016; 11(2):e0148480. PubMed ID: 26914935
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-378 suppresses myocardial fibrosis through a paracrine mechanism at the early stage of cardiac hypertrophy following mechanical stress.
Yuan J; Liu H; Gao W; Zhang L; Ye Y; Yuan L; Ding Z; Wu J; Kang L; Zhang X; Wang X; Zhang G; Gong H; Sun A; Yang X; Chen R; Cui Z; Ge J; Zou Y
Theranostics; 2018; 8(9):2565-2582. PubMed ID: 29721099
[No Abstract] [Full Text] [Related]
6. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
[TBL] [Abstract][Full Text] [Related]
7. miR-206 Mediates YAP-Induced Cardiac Hypertrophy and Survival.
Yang Y; Del Re DP; Nakano N; Sciarretta S; Zhai P; Park J; Sayed D; Shirakabe A; Matsushima S; Park Y; Tian B; Abdellatif M; Sadoshima J
Circ Res; 2015 Oct; 117(10):891-904. PubMed ID: 26333362
[TBL] [Abstract][Full Text] [Related]
8. miR-106a promotes cardiac hypertrophy by targeting mitofusin 2.
Guan X; Wang L; Liu Z; Guo X; Jiang Y; Lu Y; Peng Y; Liu T; Yang B; Shan H; Zhang Y; Xu C
J Mol Cell Cardiol; 2016 Oct; 99():207-217. PubMed ID: 27565029
[TBL] [Abstract][Full Text] [Related]
9. Loss of MicroRNA-155 protects the heart from pathological cardiac hypertrophy.
Seok HY; Chen J; Kataoka M; Huang ZP; Ding J; Yan J; Hu X; Wang DZ
Circ Res; 2014 May; 114(10):1585-95. PubMed ID: 24657879
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-101 inhibits rat cardiac hypertrophy by targeting Rab1a.
Wei L; Yuan M; Zhou R; Bai Q; Zhang W; Zhang M; Huang Y; Shi L
J Cardiovasc Pharmacol; 2015 Apr; 65(4):357-63. PubMed ID: 25850725
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy.
Huang S; Zou X; Zhu JN; Fu YH; Lin QX; Liang YY; Deng CY; Kuang SJ; Zhang MZ; Liao YL; Zheng XL; Yu XY; Shan ZX
J Cell Mol Med; 2015 Mar; 19(3):608-19. PubMed ID: 25583328
[TBL] [Abstract][Full Text] [Related]
12. Cardiac microRNA-133 is down-regulated in thyroid hormone-mediated cardiac hypertrophy partially via Type 1 Angiotensin II receptor.
Diniz GP; Lino CA; Guedes EC; Moreira Ldo N; Barreto-Chaves ML
Basic Res Cardiol; 2015 Sep; 110(5):49. PubMed ID: 26202011
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload.
Chen C; Zou LX; Lin QY; Yan X; Bi HL; Xie X; Wang S; Wang QS; Zhang YL; Li HH
Redox Biol; 2019 Jan; 20():390-401. PubMed ID: 30412827
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-27 attenuates pressure overload-Induced cardiac hypertrophy and dysfunction by targeting galectin-3.
Zhang M; Cheng K; Chen H; Tu J; Shen Y; Pang L; Wu W
Arch Biochem Biophys; 2020 Aug; 689():108405. PubMed ID: 32439330
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts.
Matkovich SJ; Wang W; Tu Y; Eschenbacher WH; Dorn LE; Condorelli G; Diwan A; Nerbonne JM; Dorn GW
Circ Res; 2010 Jan; 106(1):166-75. PubMed ID: 19893015
[TBL] [Abstract][Full Text] [Related]
16. NFATc3-dependent expression of miR-153-3p promotes mitochondrial fragmentation in cardiac hypertrophy by impairing mitofusin-1 expression.
Wang T; Zhai M; Xu S; Ponnusamy M; Huang Y; Liu CY; Wang M; Shan C; Shan PP; Gao XQ; Wang K; Chen XZ; Liu J; Xie JY; Zhang DY; Zhou LY; Wang K
Theranostics; 2020; 10(2):553-566. PubMed ID: 31903137
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of lncRNA MALAT1 Inhibits Angiotensin II-induced Hypertrophic Effects of Cardiomyocytes by Regulating SIRT4 via miR-93-5p.
Ji H; Qu J; Peng W; Yang L
Int Heart J; 2022; 63(3):602-611. PubMed ID: 35650160
[TBL] [Abstract][Full Text] [Related]
18. Cardiac hypertrophy is positively regulated by MicroRNA miR-23a.
Wang K; Lin ZQ; Long B; Li JH; Zhou J; Li PF
J Biol Chem; 2012 Jan; 287(1):589-599. PubMed ID: 22084234
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-1 downregulation increases connexin 43 displacement and induces ventricular tachyarrhythmias in rodent hypertrophic hearts.
Curcio A; Torella D; Iaconetti C; Pasceri E; Sabatino J; Sorrentino S; Giampà S; Micieli M; Polimeni A; Henning BJ; Leone A; Catalucci D; Ellison GM; Condorelli G; Indolfi C
PLoS One; 2013; 8(7):e70158. PubMed ID: 23922949
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of miR-200c attenuates AngII-induced cardiac hypertrophy via targeting the MLCK-mediated pathway.
Hu S; Cheng M; Guo X; Wang S; Liu B; Jiang H; Huang C; Wu G
J Cell Mol Med; 2019 Apr; 23(4):2505-2516. PubMed ID: 30680929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
